Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Deltagen (DGEN)
:DGEN
DGEN Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
Volume300.00
Average Volume (3M)1.13K
Market Cap
$39.00
Enterprise ValueN/A
Total Cash (Recent Filing)118.33M
Total Debt (Recent Filing)3.26M
Price to Earnings (P/E)―
Beta11.46
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding38,594,000
10 Day Avg. Volume3,403
30 Day Avg. Volume1,134
Standard Deviation197.57
R-Squared0.03
Alpha53.50
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
DGEN FAQ
What was Deltagen ’s price range in the past 12 months?
Currently, no data Available
What is Deltagen ’s market cap?
Deltagen ’s market cap is $39.00.
When is Deltagen ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Deltagen ’s earnings last quarter?
Currently, no data Available
Is Deltagen overvalued?
According to Wall Street analysts Deltagen ’s price is currently Overvalued.
Does Deltagen pay dividends?
Deltagen does not currently pay dividends.
What is Deltagen ’s EPS estimate?
Deltagen ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Deltagen have?
Deltagen has 38,594,000 shares outstanding.
What happened to Deltagen ’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Deltagen ?
Currently, no hedge funds are holding shares in DGEN
---
Company Description
Deltagen
Deltagen, Inc. engages in the provision of drug discovery tools and services to the biopharmaceutical industry. It offers a suite of programs designed to enhance the efficiency of drug discovery including access to biological models. The company was founded in 1997 and is headquartered in San Mateo, CA.
---
Technical Analysis
Bluebird Bio
―
Voyager Therapeutics
―
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
---